This article discusses The Pregnant Workers Fairness Act (“PWFA”) which creates new rights to reasonable accommodation for employees and applicants who have physical or mental conditions arising from pregnancy, childbirth or related medical conditions. The PWFA expands accommodation rights for pregnant individuals to be more in line with -- and in some respects, more expansive than -- those provided to qualified individuals with disabilities under the Americans with Disabilities Act (ADA).
This article discusses the Equal Employment Opportunity Commission's May 2023 guidance on advanced technologies in the workplace. The guidance does not unveil new policies, but instead reiterates that existing policies and practices continue to apply to new technologies.
In this multi-jurisdictional guide, explore an overview of key legal issues, rules and developments regarding derivatives across a range of jurisdictions.
Some topics discussed include smart contracts in the derivatives space and more.
In this multi-jurisdictional guide, explore an overview of key legal issues, rules and developments regarding corporate immigration across a range of jurisdictions.
Some topics discussed include a global overview of modern slavery and corporate supply chain compliance and more.
This article discusses tips to ensure that a document retention policy protects your company in the case of litigation, is compliant with current laws, and is cost-effective.
This article discusses the National Labor Relations Board (NLRB) General Counsel's memorandum explaining that noncompete agreements in employment contracts and severance agreements violate the National Labor Relations Act (NLRA) except in limited circumstances.
This blog focuses on U.S. Food and Drug Administration (FDA) published framework to guide regulatory decision-making on the use of digital health technologies (DHT) in clinical drug trials. DHTs include a wide array of technologies, including software applications that run on a phone, wearables, and environmental sensors, among others. As DHT becomes more sophisticated, the technologies have the potential to play an even larger role in health care, including clinical research.
This blog explores the U.S. Food & Drug Administration (FDA) two final guidance documents to assist with transitioning medical devices: (i) that were subject to certain enforcement policies issued during the COVID-19 Public Health Emergency (PHE), and (ii) that were issued emergency use authorizations (EUAs). These guidance documents finalize the corresponding draft guidance documents that were issued on December 23, 2021.
This blog explores physician recapitalization transactions and how complex they are and their myriad issues. At Foley, in our representation of both investors in, and sellers of, physician practices, we note how often tax issues become gating items that drive the structural aspects of the transaction.
This blog focuses on the Biden Administration’s announcement on its intention to end the COVID-19 public health emergency (PHE) on May 11, 2023. For Federally Qualified Health Centers (FQHCs), flexibilities offered under the PHE expanded opportunities to be paid for telehealth services, particularly for Medicare patients. Any FQHC relying on PHE flexibilities should begin preparing for the end of the PHE to ensure its service offerings are in compliance with post-pandemic requirements.